-
VERV Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Verve Therapeutics (VERV)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 163.48 mm | 163.48 mm | 163.48 mm | 163.48 mm | 163.48 mm | 163.48 mm |
Cash burn (monthly) | (no burn) | (no burn) | 18.97 mm | 18.88 mm | 13.20 mm | 13.13 mm |
Cash used (since last report) | n/a | n/a | 77.76 mm | 77.39 mm | 54.12 mm | 53.81 mm |
Cash remaining | n/a | n/a | 85.72 mm | 86.09 mm | 109.36 mm | 109.67 mm |
Runway (months of cash) | n/a | n/a | 4.5 | 4.6 | 8.3 | 8.4 |
13F holders | Current |
---|---|
Total holders | 176 |
Opened positions | 37 |
Closed positions | 28 |
Increased positions | 61 |
Reduced positions | 45 |
13F shares | Current |
---|---|
Total value | 347.30 bn |
Total shares | 91.94 mm |
Total puts | 203.00 k |
Total calls | 82.10 k |
Total put/call ratio | 2.5 |
Largest owners | Shares | Value |
---|---|---|
GOOG Alphabet | 12.35 mm | $59.77 bn |
GV 2017 | 12.35 mm | $145.60 mm |
BlackRock | 7.28 mm | $35.22 bn |
Millennium Management | 4.96 mm | $24.02 bn |
STT State Street | 4.25 mm | $20.59 bn |
Vanguard | 4.01 mm | $19.38 bn |
Casdin Capital | 4.00 mm | $19.34 bn |
ARCH Venture Fund X | 2.51 mm | $92.50 mm |
T. Rowe Price Investment Management | 2.43 mm | $11.74 mm |
Schonfeld Strategic Advisors | 2.41 mm | $11.65 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jan 25 | Joan Nickerson | RSU Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 40,000 |
8 Jan 25 | Joan Nickerson | Stock Option Common Stock | Grant | Acquire A | No | No | 6.01 | 225,000 | 1.35 mm | 225,000 |
8 Jan 25 | Andrew D. Ashe | RSU Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 40,000 |
8 Jan 25 | Andrew D. Ashe | Stock Option Common Stock | Grant | Acquire A | No | No | 6.01 | 225,000 | 1.35 mm | 225,000 |
8 Jan 25 | Allison Dorval | Stock Option Common Stock | Grant | Acquire A | No | No | 6.01 | 75,000 | 450.75 k | 75,000 |
8 Jan 25 | Allison Dorval | RSU Common Stock | Grant | Acquire A | No | No | 0 | 45,000 | 0.00 | 45,000 |
8 Jan 25 | Allison Dorval | Stock Option Common Stock | Grant | Acquire A | No | No | 6.01 | 258,000 | 1.55 mm | 258,000 |
8 Jan 25 | Jason Politi | RSU Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 40,000 |
8 Jan 25 | Jason Politi | Stock Option Common Stock | Grant | Acquire A | No | No | 6.01 | 225,000 | 1.35 mm | 225,000 |
8 Jan 25 | Sekar Kathiresan | Stock Option Common Stock | Grant | Acquire A | No | No | 6.01 | 150,000 | 901.50 k | 150,000 |